No excluded-states list is published on the main website
GWAS of GLP1 medication efficacy We performed a GWAS of the percentage BMI loss phenotype ( n = 15,237), and identified a strong genome-wide significant association on chromosome (chr.) 6 (Fig
Current pricing, eligibility requirements, and program details are available at galaglp1.com
MOBILE ICU IN PREHOSPITAL ACUTE STROKE CARE Andrea Higuera 1 , Nicolas Riera-Lopez 2 , Elena de Celis Ruiz 1 , Roco Alonso-Castillo 1 , Ricardo Rigual 1 , Laura Casado Fernndez 1 , Laura Gonzalez Martin 1 , Maria Alonso de Leciana 1 , Blanca Fuentes 1 , Carlos Estebas Armas 1 , Manuel Lorenzo-Dieguez 1 , Gerardo Ruiz-Ares 1 , Carlos Hervs Testal 1 , Carlos Gmez-Escalonilla 3 , Jorge Rodriguez-Pardo 1 1 Neurology Department and Stroke Center
Self-Assembled Nanomaterials for Chronic Skin Wound Healing
Recent developments in encapsulation of -lipoic acid for enhanced bioavailability and stability
